David A. Cameron
Western General Hospital
Edinburgh
UK
Name/email consistency: high
- Ibandronate: its role in metastatic breast cancer. Cameron, D., Fallon, M., Diel, I. Oncologist (2006)
- Patient management issues in metastatic bone disease. Cameron, D. Semin. Oncol. (2004)
- Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer. Cameron, D.A., Massie, C., Kerr, G., Leonard, R.C. Br. J. Cancer (2003)
- Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?. Cameron, D.A., Anderson, A., Toy, E., Evans, T.R., Le Vay, J.H., Kennedy, I.C., Grieve, R.J., Perren, T.J., Jones, A., Mansi, J., Crown, J., Leonard, R.C. Br. J. Cancer (2002)
- Breast cancer vaccines: current research and future prospects. Cameron, D.A. Expert. Rev. Vaccines (2002)
- Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. Cameron, D.A., Keen, J.C., Dixon, J.M., Bellamy, C., Hanby, A., Anderson, T.J., Miller, W.R. Eur. J. Cancer (2000)